These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 18164554)
1. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment. Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554 [TBL] [Abstract][Full Text] [Related]
2. Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind). Sabbagh MN; Walker DG; Reid RT; Stadnick T; Anand K; Lue LF Neurosci Lett; 2008 Dec; 448(2):217-20. PubMed ID: 18926877 [TBL] [Abstract][Full Text] [Related]
3. Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice. Unger C; Svedberg MM; Yu WF; Hedberg MM; Nordberg A J Pharmacol Exp Ther; 2006 Apr; 317(1):30-6. PubMed ID: 16354790 [TBL] [Abstract][Full Text] [Related]
4. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
5. Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody. Chauhan NB; Siegel GJ J Neurosci Res; 2002 Jul; 69(1):10-23. PubMed ID: 12111811 [TBL] [Abstract][Full Text] [Related]
6. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease. Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767 [TBL] [Abstract][Full Text] [Related]
7. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease. Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581 [TBL] [Abstract][Full Text] [Related]
8. Enhanced accumulation of phosphorylated alpha-synuclein in double transgenic mice expressing mutant beta-amyloid precursor protein and presenilin-1. Kurata T; Kawarabayashi T; Murakami T; Miyazaki K; Morimoto N; Ohta Y; Takehisa Y; Nagai M; Ikeda M; Matsubara E; Westaway D; Hyslop PS; Harigaya Y; Kamiya T; Shoji M; Abe K J Neurosci Res; 2007 Aug; 85(10):2246-52. PubMed ID: 17526016 [TBL] [Abstract][Full Text] [Related]
9. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Rezai-Zadeh K; Arendash GW; Hou H; Fernandez F; Jensen M; Runfeldt M; Shytle RD; Tan J Brain Res; 2008 Jun; 1214():177-87. PubMed ID: 18457818 [TBL] [Abstract][Full Text] [Related]
10. Viral-induced inflammation is accompanied by beta-amyloid plaque reduction in brains of amyloid precursor protein transgenic Tg2576 mice. Stahl T; Reimers C; Johne R; Schliebs R; Seeger J Eur J Neurosci; 2006 Oct; 24(7):1923-34. PubMed ID: 17067295 [TBL] [Abstract][Full Text] [Related]
11. The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Lord A; Kalimo H; Eckman C; Zhang XQ; Lannfelt L; Nilsson LN Neurobiol Aging; 2006 Jan; 27(1):67-77. PubMed ID: 16298242 [TBL] [Abstract][Full Text] [Related]
12. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242 [TBL] [Abstract][Full Text] [Related]
13. Age-dependent increase in lysosome-associated membrane protein 1 and early-onset behavioral deficits in APPSL transgenic mouse model of Alzheimer's disease. Hashimoto T; Ogino K; Shin RW; Kitamoto T; Kikuchi T; Shimizu N Neurosci Lett; 2010 Jan; 469(2):273-7. PubMed ID: 20025930 [TBL] [Abstract][Full Text] [Related]
14. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease. Li D; Tang J; Xu H; Fan X; Bai Y; Yang L Hippocampus; 2008; 18(7):692-8. PubMed ID: 18398851 [TBL] [Abstract][Full Text] [Related]
15. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404 [TBL] [Abstract][Full Text] [Related]
16. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269 [TBL] [Abstract][Full Text] [Related]
17. Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase. Svedberg MM; Bednar I; Nordberg A Neuropharmacology; 2004 Sep; 47(4):558-71. PubMed ID: 15380373 [TBL] [Abstract][Full Text] [Related]
18. Early changes in Abeta levels in the brain of APPswe transgenic mice--implication on synaptic density, alpha7 neuronal nicotinic acetylcholine- and N-methyl-D-aspartate receptor levels. Unger C; Hedberg MM; Mustafiz T; Svedberg MM; Nordberg A Mol Cell Neurosci; 2005 Oct; 30(2):218-27. PubMed ID: 16107318 [TBL] [Abstract][Full Text] [Related]
19. Metallothionein-I and -III expression in animal models of Alzheimer disease. Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170 [TBL] [Abstract][Full Text] [Related]
20. Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. McGowan E; Sanders S; Iwatsubo T; Takeuchi A; Saido T; Zehr C; Yu X; Uljon S; Wang R; Mann D; Dickson D; Duff K Neurobiol Dis; 1999 Aug; 6(4):231-44. PubMed ID: 10448051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]